Synergy Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-104,334
Closed -$40.6M 245
2025
Q3
$40.6M Buy
104,334
+52,167
+100% +$16.2M 1.47% 15
2025
Q2
$20.3M Buy
52,167
+50,106
+2,431% +$20.2M 2.32% 14
2025
Q1
$896K Buy
+2,061
New +$827K 0.11% 93
2023
Q3
Sell
-17,995
Closed -$8M 135
2023
Q2
$8M Sell
17,995
-2,257
-11% -$1.04M 1.98% 16
2023
Q1
$9.31M Buy
+20,252
New +$9.64M 2.23% 13
2022
Q3
Sell
-1,327
Closed -$641K 117
2022
Q2
$641K Buy
+1,327
New +$656K 0.17% 65

Other funds holding ELV

Synergy Asset Management's ELV Position: Q4 2025 in Review

Synergy Asset Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 104,334 shares — an estimated $40.6M sold.

Synergy Asset Management first reported a position in ELV in Q2 2022 and held it in 6 quarters. The position peaked at $40.6M in Q3 2025. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Synergy Asset Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Synergy Asset Management sold 104,334 Elevance Health shares in Q4 2025, an estimated $40.6M.
  • Synergy Asset Management first reported a position in Elevance Health in Q2 2022 and held it in 6 quarters.
  • Synergy Asset Management's Elevance Health position peaked at $40.6M in Q3 2025.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Synergy Asset Management's 13F filing for Q4 2025, filed 13 Jan 2026.